BioCryst Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of BioCryst Pharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-04 | $-0.07 | $-0.06 | -16.7 % |
Jun 2024 | 2024-08-05 | $-0.06 | $-0.17 | 64.7 % |
Mar 2024 | 2024-05-06 | $-0.17 | $-0.21 | 19.1 % |
Dec 2023 | 2024-02-26 | $-0.28 | $-0.24 | -16.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-04 | $117.09M | $112.50M | 4.08 % |
Jun 2024 | 2024-08-05 | $109.33M | $98.47M | 11.0 % |
Mar 2024 | 2024-05-06 | $92.76M | $85.60M | 8.37 % |
Dec 2023 | 2024-02-26 | $93.40M | $90.01M | 3.77 % |
BioCryst Pharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 4, 2024 for Q3.
BioCryst Pharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 4, 2024 for Q3 and the Actual EPS was $-0.07, which missed the estimate of $-0.06.
BioCryst Pharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 4, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.